StonvexLoading…
StonvexStonvexStonvexCore line items from CDP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $42.07M | $75.55M | $60.18M | $154.63M |
Operating Income | $157.68M | $143.83M | $-73.50M | $147.95M |
Net Income | $159.53M | $143.94M | $-74.35M | $178.82M |
EPS (Diluted) | $1.34 | $1.23 | $-0.67 | $1.53 |
Total Assets | $4.70B | $4.25B | $4.25B | $4.26B |
Total Liabilities | $3.11B | $2.69B | $2.70B | $2.51B |
Cash & Equivalents | $274.99M | $38.28M | $167.82M | $12.34M |
Free Cash Flow OCF − CapEx | $288.87M | $299.61M | $255.77M | $229.45M |
Shares Outstanding | 113.21M | 112.70M | 112.56M | 112.42M |